Literature DB >> 19245921

Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality?

Peter T Hallowell1, Thomas A Stellato, David A Yao, Ann Robinson, Margaret M Schuster, Kristen N Graf.   

Abstract

BACKGROUND: Revisional bariatric surgery may be necessary due to inadequate weight loss or postoperative complications of the primary operation. We sought to identify the reasons for revision, characteristics of the surgery, and outcomes. We hypothesize that revisional surgery, although technically challenging, can produce desirable outcomes.
METHODS: Patients undergoing bariatric surgery at our institution between 1998 and 2007 were reviewed from a prospective database. Patients who had revisional surgery were compared to those who had primary surgery.
RESULTS: We have identified 46 of 1,038 patients who underwent revisional surgery. Twenty of 46 had a primary Roux-en-Y gastric bypass. The most common indication for revisions is inadequate weight loss secondary to gastrogastric fistula (15/20). Leaks occurred more frequently following revisional surgeries (11% vs 1.2%), but intensive care unit (ICU) utilization was less (11% vs 4.4%) and mortality was lower (0% vs .3%) with bariatric revision surgery.
CONCLUSIONS: Although we saw a 9-fold increase in leaks, a 2-5 fold increase in ICU utilization, and 1.5-fold increase in length of stay, our mortality rate was zero. In experienced hands, bariatric revision surgery can be performed to produce desirable outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19245921     DOI: 10.1016/j.amjsurg.2008.11.011

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  41 in total

1.  The big fat bariatric bandwagon.

Authors:  J H Pinkney; A B Johnson; E A M Gale
Journal:  Diabetologia       Date:  2010-09       Impact factor: 10.122

2.  Conversion from band to bypass in two steps reduces the risk for anastomotic strictures.

Authors:  Yves Van Nieuwenhove; Wim Ceelen; Katrien Van Renterghem; Dirk Van de Putte; Tom Henckens; Piet Pattyn
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

3.  Laparoscopic Conversion of Gastric Bypass Complication to Sleeve Gastrectomy: Technique and Early Results.

Authors:  Chung-Yen Chen; Wei-Jei Lee; Hui-Ming Lee; Jung-Chien Chen; Kong-Han Ser; Yi-Chih Lee; Shu-Chun Chen
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

4.  Outcomes of Robot-Assisted Roux-en-Y Gastric Bypass as a Reoperative Bariatric Procedure.

Authors:  Vivek Bindal; Raquel Gonzalez-Heredia; Enrique Fernando Elli
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

5.  Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass.

Authors:  Barham K Abu Dayyeh; David B Lautz; Christopher C Thompson
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-17       Impact factor: 11.382

6.  Revisional metabolic/bariatric surgery: a moral obligation.

Authors:  Henry Buchwald
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

7.  Video Revisional Gastric Bypass After Vertical Banded Gastroplasty by a Hybrid Technique: Robotic and Laparoscopic.

Authors:  Mohammed Ghunaim; Constance Laroye; Francois Pattou; Robert Caiazzo
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

8.  Endoscopic repair of small symptomatic gastrogastric fistulas after gastric bypass surgery: a single center experience.

Authors:  Atul Bhardwaj; Robert N Cooney; Andrew Wehrman; Ann M Rogers; Abraham Mathew
Journal:  Obes Surg       Date:  2010-08       Impact factor: 4.129

9.  Robotically assisted revision of bariatric surgeries is safe and effective to achieve further weight loss.

Authors:  Brad Snyder; Todd Wilson; Vicky Woodruff; Erik Wilson
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

10.  Technical Feasibility of a Murine Model of Sleeve Gastrectomy with Ileal Transposition.

Authors:  Lee D Ying; Gregory A Breuer; Matthew O Hubbard; Geoffrey S Nadzam; John Hwa; Kathleen A Martin
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.